These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cosmetic use of botulinum A exotoxin for the aging neck. Brandt FS; Bellman B Dermatol Surg; 1998 Nov; 24(11):1232-4. PubMed ID: 9834744 [TBL] [Abstract][Full Text] [Related]
3. A case of dysphagia following botulinum toxin injection for neck rejuvenation. Phothong W; Wanitphakdeedecha R; Keskool P; Manuskiatti W J Cosmet Dermatol; 2017 Mar; 16(1):15-17. PubMed ID: 27637174 [TBL] [Abstract][Full Text] [Related]
4. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks? Kapoor R; Shome D; Jain V; Dikshit R Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041 [TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxin Use in the Upper Face. Qaqish C Atlas Oral Maxillofac Surg Clin North Am; 2016 Sep; 24(2):95-103. PubMed ID: 27499468 [No Abstract] [Full Text] [Related]
9. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives. Lowe NJ Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction. Sepehr A; Chauhan N; Alexander AJ; Adamson PA Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497 [TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin Treatment for Mild to Moderate Platysma Bands: A Systematic Review of Efficacy, Safety, and Injection Technique. Sugrue CM; Kelly JL; McInerney N Aesthet Surg J; 2019 Jan; 39(2):201-206. PubMed ID: 30052764 [TBL] [Abstract][Full Text] [Related]
12. [Controversy: botulinum toxin, does it prevent cutaneous aging?]. Cohen-Letessier A Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S89-91. PubMed ID: 19576492 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin for the treatment of neck lines and neck bands. Brandt FS; Boker A Dermatol Clin; 2004 Apr; 22(2):159-66. PubMed ID: 15222576 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type B (Myobloc). Baumann L; Black L Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517 [TBL] [Abstract][Full Text] [Related]
15. Sixth nerve palsy following botulinum toxin injection for facial rejuvenation. Dolar Bilge A; Sadigov F; Salar-Gomceli S Cutan Ocul Toxicol; 2017 Jun; 36(2):193-194. PubMed ID: 27558865 [TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin below the eyes. Carruthers J; Carruthers A Int Ophthalmol Clin; 2005; 45(3):133-41. PubMed ID: 15970772 [No Abstract] [Full Text] [Related]
17. Facial skin rejuvenation in the Asian patient. Kim MM; Byrne PJ Facial Plast Surg Clin North Am; 2007 Aug; 15(3):381-6, vii. PubMed ID: 17658434 [TBL] [Abstract][Full Text] [Related]
19. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044 [TBL] [Abstract][Full Text] [Related]
20. Injectable agents for facial rejuvenation: botulinum toxin and dermal filling agents. Mandeville JT; Rubin PA Int Ophthalmol Clin; 2004; 44(1):189-212. PubMed ID: 14704531 [No Abstract] [Full Text] [Related] [Next] [New Search]